First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).
Publication
, Journal Article
Levy, EI; Siddiqui, AH; Crumlish, A; Snyder, KV; Hauck, EF; Fiorella, DJ; Hopkins, LN; Mocco, J
Published in: Stroke
November 2009
BACKGROUND AND PURPOSE: Acute revascularization is associated with improved outcomes in ischemic stroke patients. However, it is unclear which method of intraarterial intervention, if any, is ideal. Numerous case series and cardiac literature parallels suggest that acute stenting may yield high revascularization levels with low associated morbidity. We therefore conducted a Food and Drug Administration-approved prospective pilot trial to evaluate the safety of intracranial stenting for acute ischemic stroke. METHODS: Eligibility criteria included presentation
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Stroke
DOI
EISSN
1524-4628
Publication Date
November 2009
Volume
40
Issue
11
Start / End Page
3552 / 3556
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Stroke
- Stents
- Prospective Studies
- Neurology & Neurosurgery
- Middle Aged
- Male
- Humans
- Follow-Up Studies
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, E. I., Siddiqui, A. H., Crumlish, A., Snyder, K. V., Hauck, E. F., Fiorella, D. J., … Mocco, J. (2009). First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke, 40(11), 3552–3556. https://doi.org/10.1161/STROKEAHA.109.561274
Levy, Elad I., Adnan H. Siddiqui, Annemarie Crumlish, Kenneth V. Snyder, Erik F. Hauck, David J. Fiorella, L Nelson Hopkins, and J. Mocco. “First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).” Stroke 40, no. 11 (November 2009): 3552–56. https://doi.org/10.1161/STROKEAHA.109.561274.
Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 2009 Nov;40(11):3552–6.
Levy, Elad I., et al. “First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).” Stroke, vol. 40, no. 11, Nov. 2009, pp. 3552–56. Pubmed, doi:10.1161/STROKEAHA.109.561274.
Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, Hopkins LN, Mocco J. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 2009 Nov;40(11):3552–3556.
Published In
Stroke
DOI
EISSN
1524-4628
Publication Date
November 2009
Volume
40
Issue
11
Start / End Page
3552 / 3556
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Stroke
- Stents
- Prospective Studies
- Neurology & Neurosurgery
- Middle Aged
- Male
- Humans
- Follow-Up Studies